We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
iBio Inc | AMEX:IBIO | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.04 | 2.33% | 1.76 | 1.80 | 1.72 | 1.77 | 60,203 | 23:44:36 |
Sancha Salgueiro, Ph.D., MBA, a well-known expert and business development executive focussed on plant-made protein technologies and products, will be presenting:
“I am honored to have this opportunity to highlight the significant product flexibility, time- and cost-savings provided by iBio’s plant-based technology platform and CDMO offering to my fellow researchers and industry participants and, in so doing, help support the development of new business relationships and commercial collaborations for iBio in Brazil and internationally,” said Dr. Salgueiro.
“We are pleased to be invited to present at this international conference focusing on the latest advances and achievements in the field of plant-based biopharmaceutical development and manufacture of recombinant antibodies and vaccines,” said Robert B. Kay, iBio’s Chairman and CEO. “We look forward to continuing our collaborative relationship with Bio-Manguinhos/Fiocruz as it implements its planned, important expansion of capabilities in the plant-based biopharmaceutical field.”
About iBio, Inc.
iBio, a leader in developing plant-based biopharmaceuticals, provides a range of product and process development, analytical, and manufacturing services at the large-scale development and manufacturing facility of its subsidiary iBio CDMO, LLC in Bryan, Texas. The facility houses laboratory and pilot-scale operations, as well as large-scale automated hydroponic systems capable of growing over four million plants as "in process inventory" and delivering over 300 kilograms of therapeutic protein pharmaceutical active ingredient per year. For more information please visit www.ibioinc.com.
FORWARD-LOOKING STATEMENTS
STATEMENTS INCLUDED IN THIS NEWS RELEASE RELATED TO IBIO, INC. MAY CONSTITUTE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. SUCH STATEMENTS INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES SUCH AS COMPETITIVE FACTORS, TECHNOLOGICAL DEVELOPMENT, MARKET DEMAND, AND THE COMPANY'S ABILITY TO OBTAIN NEW CONTRACTS AND ACCURATELY ESTIMATE NET REVENUES DUE TO VARIABILITY IN SIZE, SCOPE, AND DURATION OF PROJECTS. FURTHER INFORMATION ON POTENTIAL RISK FACTORS THAT COULD AFFECT THE COMPANY'S FINANCIAL RESULTS CAN BE FOUND IN THE COMPANY'S REPORTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.
Contact:
Stephen KilmerInvestor Relations(646) 274-3580 skilmer@ibioinc.com
Source: iBio, Inc.
1 Year iBio Chart |
1 Month iBio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions